Page last updated: 2024-09-05

muraglitazar and Neoplasms

muraglitazar has been researched along with Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arnold, LL; Cohen, SM; Dominick, MA; Minnema, D; Sanderson, TP; Schilling, BE; Tannehill-Gregg, SH; Ulland, B; Voelker, R; Waites, CR	1

Other Studies

1 other study(ies) available for muraglitazar and Neoplasms

Article	Year
Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazar. Toxicological sciences : an official journal of the Society of Toxicology, 2007, Volume: 98, Issue:1 Topics: Animals; Carcinogenicity Tests; Carcinogens; Dose-Response Relationship, Drug; Female; Glycine; Hypoglycemic Agents; Male; Mice; Mice, Inbred ICR; Neoplasms; Oxazoles; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Survival Analysis; Urinalysis	2007

Article

Year

Rodent carcinogenicity profile of the antidiabetic dual PPAR alpha and gamma agonist muraglitazar.

Toxicological sciences : an official journal of the Society of Toxicology, 2007, Volume: 98, Issue:1

Topics: Animals; Carcinogenicity Tests; Carcinogens; Dose-Response Relationship, Drug; Female; Glycine; Hypoglycemic Agents; Male; Mice; Mice, Inbred ICR; Neoplasms; Oxazoles; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Survival Analysis; Urinalysis

2007